August 08, 2025

INSL5 Rise Tied to Diarrhoea Severity, Treatment

Circulating Insulin-like peptide 5 concentrations may reflect colonic exposure to bile acids and help stratify treatment response in patients with chronic diarrhoea, including those with irritable bowel syndrome with diarrhoea and bile acid diarrhoea.

Conexiant

August 07, 2025

Allogeneic Islet Transplant Shows Promise Without Immunosuppression

First-in-human trial shows genetically engineered islet cells restore insulin secretion in type 1 diabetes without triggering immune rejection.

Conexiant

August 07, 2025

AI Matches Resident Accuracy in Thyroid Imaging, Study Shows

ChatGPT-4 Vision analyzes thyroid ultrasound images with accuracy comparable to resident physicians, suggesting its potential use in real-time diagnostic support.

Conexiant

August 06, 2025

DASH4D: Sodium Reduction Lowered Blood Pressure in T2D

Researchers found that a lower sodium DASH-style diet tailored for type 2 diabetes reduced blood pressure in adults receiving antihypertensive treatment.

Conexiant

August 06, 2025

Do Retail Health Kiosks Tell Different Story?

Analysis of U.S. retail health kiosk users reveals that nearly half had high blood pressure, with the highest prevalence among non-Hispanic Black adults.

Conexiant

August 05, 2025

Nature’s Mouthwash: Better Breath, Fewer Risks?

Researchers report significant improvements in breath odor and oral health after four weeks using a natural essential oil rinse in patients with obesity and periodontitis.

Conexiant

July 17, 2025

Once-Weekly Insulin Effective and Safe Alternative to Daily Dosing

A 78-week international trial found that a once-weekly insulin injection effectively lowered blood sugar in adults with type 2 diabetes, performing similarly to a once-daily insulin regimen with comparable safety.

Conexiant

August 05, 2025

Weight Regain Persists After Anti-Obesity Treatment

A new meta-analysis of 11 randomized controlled trials found that patients began regaining weight as early as 8 weeks after discontinuing anti-obesity medications, with weight gain continuing through 52 weeks.

Conexiant

July 28, 2025

Race, Sex, and Steps to Cognition

Walking significantly slows cognitive decline in APOE ε4 carriers, with benefits varying by sex and race in 10-year study.

Conexiant